A detailed history of Cutler Group LP transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Cutler Group LP holds 810 shares of SWTX stock, worth $34,830. This represents 0.01% of its overall portfolio holdings.

Number of Shares
810
Previous 400 102.5%
Holding current value
$34,830
Previous $3,000 1200.0%
% of portfolio
0.01%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

BUY
$36.5 - $52.5 $29,565 - $42,525
810 New
810 $39,000
Q2 2022

Aug 04, 2022

BUY
$18.36 - $60.07 $42,228 - $138,161
2,300 Added 230.0%
3,300 $81,000
Q1 2022

Apr 14, 2022

BUY
$48.97 - $65.46 $48,970 - $65,459
1,000 New
1,000 $56,000

Others Institutions Holding SWTX

About SpringWorks Therapeutics, Inc.


  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $2.68B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.